Scientific and Medical Equipment House Company CJSC
SAU:4014
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
SA |
S
|
Scientific and Medical Equipment House Company CJSC
SAU:4014
|
1.4B SAR | 14.7 | |
US |
Cigna Corp
NYSE:CI
|
96.1B USD | 9.6 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
87.8B EUR | 9.6 | |
US |
CVS Health Corp
NYSE:CVS
|
77.3B USD | 9.2 | ||
DE |
Fresenius SE & Co KGaA
XETRA:FRE
|
17.1B EUR | 10.7 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
16.6B USD | 11.7 | ||
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.8B USD | 11.1 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.7B EUR | 6.6 | |
US |
DaVita Inc
NYSE:DVA
|
12.6B USD | 8.5 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
11.5B EUR | 6.5 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -23.3 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.